4
Changes in Ownership
Citius Pharmaceuticals, Inc. Filed Acc 0001477932-17-004615
Options or other derivatives
- President and CEO acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
HOLUBIAK MYRON Z · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-09-15 | Grant or award : show line 1 in the form Options to Purchase Common Stock | +40,000 | 40,000 | D |
Loading xslF345X03/form4.xml…